Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes.
Hu J, Yang C, Wang H, Li J, Tan X, Wang J, Zhang B, Zhao Y. Hu J, et al. Expert Opin Pharmacother. 2019 Oct;20(14):1679-1687. doi: 10.1080/14656566.2019.1645124. Epub 2019 Jul 23. Expert Opin Pharmacother. 2019. PMID: 31335214 Review.
Areas covered: This article provides a comprehensive review of the latest data on alogliptin benzoate, including hypoglycemic activity and safety. Expert opinion: The cumulative evidence for alogliptin benzoate is robust with regards to glycemic effica …
Areas covered: This article provides a comprehensive review of the latest data on alogliptin benzoate, including hypoglycemic …
Alogliptin benzoate for the treatment of type 2 diabetes.
Rendell M, Drincic A, Andukuri R. Rendell M, et al. Expert Opin Pharmacother. 2012 Mar;13(4):553-63. doi: 10.1517/14656566.2012.656088. Epub 2012 Feb 1. Expert Opin Pharmacother. 2012. PMID: 22296609 Review.
The glucose-lowering effect of this agent is discussed as monotherapy and in combination with metformin, sulfonylurea, piogilitazone and insulin. The potential adverse effects of alogliptin are summarized. Alogliptin is compared with the other availabl …
The glucose-lowering effect of this agent is discussed as monotherapy and in combination with metformin, sulfonylurea, piogili …
A guide for using experimental design in chromatographic method development: applied to the analysis of selected anti-diabetic pharmaceutical combinations.
Ayoub BM, Abdel-Aziz O. Ayoub BM, et al. Pharmazie. 2016 Dec 1;71(12):683-690. doi: 10.1691/ph.2016.6095. Pharmazie. 2016. PMID: 29441996
A guide experimental design in chromatographic method development was described and applied successfully to the analysis of different recently approved anti-diabetic pharmaceutical combinations. Enhancement of UHPLC analysis of alogliptin benzoate either with …
A guide experimental design in chromatographic method development was described and applied successfully to the analysis of different recent …